- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Egyptian International Pharma (PHAR)
Egyptian International Pharma stock price live, this page displays EGX PHAR stock exchange data. View the PHAR premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Egyptian International Pharma real time stock price chart below.
What Is the Egyptian International Pharma Stock Price Today?
The Egyptian International Pharma stock price today is 52.99.
What Is the Stock Symbol for Egyptian International Pharma?
The stock symbol for Egyptian International Pharma is "PHAR."
What Stock Exchange Does Egyptian International Pharma Trade On?
Egyptian International Pharma is listed and trades on the Egypt stock exchange.
Is Egyptian International Pharma a Good Stock to Buy?
Determining whether Egyptian International Pharma—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PHAR quote. (ISIN: EGS38081C013)
What Is the Egyptian International Pharma Stock Price Today?
The Egyptian International Pharma stock price today is 52.99.
What Is the Stock Symbol for Egyptian International Pharma?
The stock symbol for Egyptian International Pharma is "PHAR."
What Stock Exchange Does Egyptian International Pharma Trade On?
Egyptian International Pharma is listed and trades on the Egypt stock exchange.
Is Egyptian International Pharma a Good Stock to Buy?
Determining whether Egyptian International Pharma—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PHAR quote. (ISIN: EGS38081C013)
Egypt
Currency in EGP
52.99
+0.19(+0.36%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
52.77
53.26
52 wk Range
35.06
58.00
PHAR Scorecard
Full Analysis
Operates with a significant debt burden
Unusual trading volume
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
52.7753.26
52 wk Range
35.0658.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(5.68%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(5.68%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
PHAR Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
90.00
Upside
+69.84%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Buy
Egyptian International Pharma Company Profile
Egyptian International Pharmaceutical Industries Company manufactures and sells pharmaceutical ampoules in Egypt and internationally. The company offers analgesics and antipyretic; analgesics and anti-inflammatory; anti-infective; antihistamine; cardiovascular and metabolic; corticosteroids; gastrointestinal tract; nervous system; ophthalmic; respiratory; topical ointment and cream; vitamins; and miscellaneous products. It also exports its products. Egyptian International Pharmaceutical Industries Company was incorporated in 1980 and is based in 10th of Ramadan City, Egypt.
Compare PHAR to Peers and Sector
Metrics to compare | PHAR | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPHARPeersSector | |
|---|---|---|---|---|
P/E Ratio | 9.7x | 9.7x | −0.5x | |
PEG Ratio | −0.28 | 0.02 | 0.00 | |
Price/Book | 1.8x | 1.9x | 2.6x | |
Price / LTM Sales | 0.9x | 1.4x | 3.2x | |
Upside (Analyst Target) | 70.5% | −0.8% | 45.4% | |
Fair Value Upside | Unlock | 16.0% | 6.7% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 90.00
(+69.84% Upside)
Earnings
Latest Release
May 28, 2025
EPS / Forecast
2.14 / --
Revenue / Forecast
2.30B / --
People Also Watch
FAQ
What Is the EIPICO (PHAR) Stock Price Today?
The EIPICO stock price today is 52.99
What Stock Exchange Does EIPICO Trade On?
EIPICO is listed and trades on the Egypt Stock Exchange stock exchange.
What Is the Stock Symbol for EIPICO?
The stock symbol for EIPICO is "PHAR."
Does EIPICO Pay Dividends? What’s The Current Dividend Yield?
The EIPICO dividend yield is 5.68%.
What Is the EIPICO Market Cap?
As of today, EIPICO market cap is 7.88B.
What Is EIPICO's Earnings Per Share (TTM)?
The EIPICO EPS (TTM) is 5.45.
When Is the Next EIPICO Earnings Date?
EIPICO will release its next earnings report on 31 Aug 2025.
From a Technical Analysis Perspective, Is PHAR a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has EIPICO Stock Split?
EIPICO has split 3 times.
How Many Employees Does EIPICO Have?
EIPICO has 0 employees.
What is the current trading status of EIPICO (PHAR)?
As of 17 July 2025, EIPICO (PHAR) is trading at a price of 52.99, with a previous close of 52.80. The stock has fluctuated within a day range of 52.77 to 53.26, while its 52-week range spans from 35.06 to 58.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.